BVF INC/IL Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001056807

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q4 2024 · 53 positions · Total reported value $2.95B · Top-10 concentration 70.1% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 34.8% · 5 new · 9 cut · 2 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +26.0% · vs SPY +11.2% · Prev Value $3.14B — last quarter positions weighted by this quarter price moves · ranking

In its Q4 2024 13F filing, BVF INC/IL disclosed 53 equity positions with a combined reported value of $2.95B. The filing implies a focused portfolio: its ten largest positions account for 70.1% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2024 were MLTX ($1.07B), KYMR ($207.66M), RVMD ($182.88M). By sector, the heaviest allocations are Health Care 87.3%, Materials 0.0%. Versus the prior quarter, allocation shifted toward Other (+1.4pp) and away from Health Care (-1.4pp).

Versus the prior quarter, BVF INC/IL opened 5 new positions, trimmed 9 and fully exited 2, a turnover rate of 34.8% of positions. The portfolio's overlap with the prior quarter was 80% of names.

The largest new positions opened in Q4 2024 were SEPN ($56.15M), GLUE ($19.19M), ITOS ($17.86M).

Of the 2 positions fully exited versus the prior quarter, the largest were IONS ($58.16M), IDYA ($44.67M), CGON ($37.53M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2024)

  • SEPN SEPTERNA INC · $56.15M
  • GLUE MONTE ROSA THERAPEUTICS · $19.19M
  • ITOS ITEOS THERAPEUTICS INC · $17.86M
  • RAPT RAPT THERAPEUTICS INC · $14.60M
  • PVLA PALVELLA THERAPEUTICS INC NE · $8.36M

Fully Exited (vs previous quarter)

  • IONS IONIS PHARMACEUTICALS INC · prev qtr: $58.16M
  • IDYA IDEAYA BIOSCIENCES INC · prev qtr: $44.67M
  • CGON CG ONCOLOGY INC · prev qtr: $37.53M
  • NAMS NEWAMSTERDAM PHARMA COMPANY · prev qtr: $25.26M
  • VTGN VISTAGEN THERAPEUTICS INC · prev qtr: $6.02M
  • PIRS PIERIS PHARMACEUTICALS INC · prev qtr: $4.31M
  • MTEM MOLECULAR TEMPLATES INC · prev qtr: $733.74K

Insider Transactions (Form 4)

Latest BVF INC/IL buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-07-14 U XOMA Royalty Corp 772,000 — SEC filing
2026-07-14 U XOMA Royalty Corp 412,000 — SEC filing
2026-07-14 U XOMA Royalty Corp 2,773,545 — SEC filing
2026-07-14 U XOMA Royalty Corp 3,635,758 — SEC filing
2026-06-26 Sell Kymera Therapeutics, Inc. 51,858 $106.50 SEC filing
2026-06-26 Sell Kymera Therapeutics, Inc. 113,289 $106.50 SEC filing
2026-06-26 Sell Kymera Therapeutics, Inc. 627,597 $106.50 SEC filing
2026-06-26 Sell Kymera Therapeutics, Inc. 837,914 $106.50 SEC filing

All insider transactions →

Fund Profile

BVF INC files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 44 positions worth $3.91B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 44 positions · $3.91B reported value (Q2 2026)
  • Top 10 holdings = 65.6% of reported value
  • Largest position: RVMD (REVOLUTION MEDICINES INC) at 14.2%
  • Average position size: $88.89M

Sector Tilt

  • Health Care 91.6%
  • Financials 0.1%
  • Materials 0.0%
  • (classified holdings cover 92% of value)

Quarterly Activity

  • Q2 2026: 5 new, 6 added, 9 reduced, 2 exited
  • 24 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 87.3%
Materials 0.0%
Other 12.7%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 19.75M $1.07B 36.25%
36.25%
Reduce
2 5.16M $207.66M 7.04%
7.04%
Hold
3 4.18M $182.88M 6.20%
6.20%
Add
4 1.39M $117.44M 3.98%
3.98%
Add
5 2.80M $115.64M 3.92%
3.92%
Reduce
6 3.63M $95.49M 3.24%
3.24%
Hold
7 1.90M $73.34M 2.49%
2.49%
Add
8 10.40M $72.80M 2.47%
2.47%
Hold
9 5.75M $70.04M 2.37%
2.37%
Hold
10 4.31M $63.08M 2.14%
2.14%
Reduce
11 2.45M $56.15M 1.90%
1.90%
New
12 3.94M $54.82M 1.86%
1.86%
Reduce
13 19.52M $52.71M 1.79%
1.79%
Hold
14 2.29M $52.60M 1.78%
1.78%
Add
15 1.77M $48.04M 1.63%
1.63%
Reduce
16 3.47M $45.37M 1.54%
1.54%
Hold
17 1.57M $43.16M 1.46%
1.46%
Hold
18 6.90M $38.94M 1.32%
1.32%
Add
19 7.00M $35.91M 1.22%
1.22%
Hold
20 1.07M $35.28M 1.20%
1.20%
Reduce
21 4.33M $33.89M 1.15%
1.15%
Reduce
22 5.72M $33.32M 1.13%
1.13%
Reduce
23 1.09M $29.37M 1.00%
1.00%
Add
24 6.29M $25.93M 0.88%
0.88%
Hold
25 5.30M $25.03M 0.85%
0.85%
Hold
26 2.37M $24.42M 0.83%
0.83%
Reduce
27 2.57M $22.36M 0.76%
0.76%
Reduce
28 16.55M $20.03M 0.68%
0.68%
Hold
29 2.76M $19.19M 0.65%
0.65%
New
30 2.33M $17.86M 0.60%
0.60%
New
31 8.75M $15.66M 0.53%
0.53%
Hold
32 2.67M $14.88M 0.50%
0.50%
Reduce
33 9.24M $14.60M 0.49%
0.49%
New
34 2.11M $14.01M 0.47%
0.47%
Reduce
35 10.33M $13.54M 0.46%
0.46%
Hold
36 594.28K $13.50M 0.46%
0.46%
Add
37 2.10M $10.86M 0.37%
0.37%
Add
38 2.99M $9.09M 0.31%
0.31%
Hold
39 8.90M $8.90M 0.30%
0.30%
Hold
40 696.55K $8.36M 0.28%
0.28%
New
41 1.04M $7.70M 0.26%
0.26%
Add
42 4.01M $6.57M 0.22%
0.22%
Reduce
43 1.35M $6.46M 0.22%
0.22%
Add
44 5.23M $5.39M 0.18%
0.18%
Hold
45 3.85M $3.60M 0.12%
0.12%
Hold
46 917.83K $3.51M 0.12%
0.12%
Hold
47 1.81M $3.08M 0.10%
0.10%
Hold
48 9.54M $2.38M 0.08%
0.08%
Hold
49 339.55K $2.10M 0.07%
0.07%
Hold
50 2.97M $1.67M 0.06%
0.06%
Hold

FAQ

What did BVF INC/IL buy in 2024-Q4?

In its 2024-Q4 13F filing, BVF INC/IL reported 53 equity positions worth $2.95B in aggregate; its largest disclosed positions were MLTX ($1.07B), KYMR ($207.66M), RVMD ($182.88M).

How large is BVF INC/IL's portfolio?

BVF INC/IL reported $2.95B of long equity holdings across 53 positions as of 2024-Q4. Top-10 holdings account for 70.1% of reported value.

What is BVF INC/IL's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/bvf-inc-il/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →